Dialysis Facility Infection Prevention & Control Consulting

Dialysis Facility Infection Prevention & Control Consulting

Dialysis patients are among the most infection-vulnerable patient populations in outpatient healthcare. Bloodstream infections associated with vascular access are the leading cause of hospitalization and the second leading cause of death in the ESRD population. Hepatitis B transmission in dialysis settings — while dramatically reduced by vaccination and isolation practices — remains a persistent risk when infection control practices are inconsistently applied. We assess dialysis infection prevention programs with the technical depth these risks demand.

Overview

Infection prevention and control in dialysis facilities operates within a specific clinical and regulatory framework that differs significantly from other healthcare settings. The infection control condition at 42 CFR Part 494.30 establishes requirements that are specifically designed for the risks inherent in the dialysis environment — including the requirement to screen all patients for hepatitis B surface antigen and antibody status, the requirement to isolate HBsAg-positive patients in dedicated equipment areas, the prohibition on sharing of equipment between patients, and the specific hand hygiene and personal protective equipment requirements applicable to the dialysis treatment setting.

CDC has published specific infection prevention guidelines for dialysis facilities — the CDC Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients — that are incorporated by reference into the ESRD interpretive guidance and that provide the technical foundation for surveyor evaluation of infection control compliance. Facilities that are not familiar with these specific guidelines are often surprised by the technical specificity of surveyor questions and observations during infection control assessment.

Infection Control Areas We Assess

Hepatitis B Screening and Vaccination Compliance

The Conditions for Coverage require that all patients be screened for hepatitis B surface antigen and antibody at admission and at defined intervals — and that HBsAg-negative patients with inadequate antibody response be offered hepatitis B vaccination. We audit HBV screening and vaccination documentation for completeness and timeliness, and assess the facility's response to patients with indeterminate or declining antibody levels.

HBsAg-Positive Patient Isolation

Patients who are HBsAg-positive must be dialyzed in a dedicated isolation area using equipment that is not shared with HBsAg-negative patients — a requirement that is both clinically important and operationally demanding. We assess the adequacy of isolation facilities, the consistency with which isolation procedures are applied, and the documentation of isolation practices for HBsAg-positive patients.

Equipment Disinfection and Non-Sharing Compliance

The dialysis equipment used for each patient — including the dialysis machine, blood pressure cuffs, hemostats, and other patient-specific supplies — must be disinfected between patients or dedicated to a single patient. We observe equipment disinfection practices directly and assess the policies and training that govern non-sharing compliance.

Vascular Access Infection Prevention

Bloodstream infections related to dialysis vascular access — particularly catheter-related bloodstream infections — are one of the most serious patient safety risks in the dialysis setting. We assess vascular access care practices — including catheter exit site care, connection and disconnection procedures, and the use of antiseptic techniques — against CDC recommendations and facility-specific protocols.

Hand Hygiene Compliance

Hand hygiene compliance in dialysis settings requires frequent, consistent hand hygiene by all staff who touch patients, equipment, or surfaces in the patient care area — and hand hygiene compliance observations are a specific component of CMS ESRD surveys. We observe hand hygiene practices directly and assess training, monitoring, and feedback systems for hand hygiene compliance.

Environmental Cleaning and Disinfection

The dialysis treatment area must be cleaned and disinfected at defined intervals and after each patient treatment — using disinfectants that are appropriate for the surfaces and equipment involved. We assess environmental cleaning and disinfection protocols, product selection, and documentation practices.

Bloodborne Pathogen Compliance

OSHA bloodborne pathogen standards apply fully to dialysis facilities — requiring exposure control plans, engineering controls, PPE availability and use, and hepatitis B vaccination for all at-risk employees. We assess bloodborne pathogen compliance as part of the infection control assessment.

HAI Surveillance System

The facility's infection surveillance system must capture and analyze data on dialysis-associated infections — including vascular access infections, bacteremia, and local access site infections — and must use that data to drive infection prevention improvement. We assess the adequacy of the facility's HAI surveillance methodology, data completeness, and the connection between surveillance findings and quality improvement action.